title: Effect of Sho-saiko-to extract on hepatic inflammation and fibrosis in dimethylnitrosamine induced liver injury rats.
abstract: Sho-saiko-to extract, a Chinese herbal medicine, is widely used for treatment of chronic hepatitis in Japan. However, it is not clear what conditions Sho-saiko-to extract improves hepatic inflammation and fibrosis. We therefore induced various stages of liver injury in model rats and administered Sho-saiko-to extract. We then evaluated the liver inflammation and liver fibrosis-improving effects of Sho-saiko-to extract. The liver injury model rats were produced by administration of various doses of dimethylnitrosamine (DMN) and Sho-saiko-to extract was administered to these rats. Then the liver inflammation and fibrosis-improving effects of Sho-saiko-to extract were evaluated according to L-asparate aminotransferase (AST), L-alanine aminotransferase (ALT), liver retinoid levels, levels of hydroxyproline, Transforming Growth Factor-beta (TGF-beta), and the liver fibrosis area. These indicators depended on the total doses of DMN. The ability of Sho-saiko-to extract to improve liver inflammation and fibrosis was limited to the following levels of the respective parameters: AST levels (234-264 U/l), ALT levels (208-232 U/l), TGF-beta levels (1102-1265 pg/g liver tissue), hydroxyproline levels (633-719 nmol/g liver tissue), and liver fibrosis area (9.7-10.6 times for normal rat). These findings suggested that Sho-saiko-to extract is effective in the treatment of liver inflammation and fibrosis up to a certain degree of severity, but it produces no improvement in more severe cases.
authors.affiliation: Department of Pharmacy, Kochi Medical School Hospital, Kochi, Japan. kusunosm@kochi-ms.ac.jp
authors.forename: Masahiko
authors.initials: M
authors.lastname: Kusunose
authors.forename: Bing
authors.initials: B
authors.lastname: Qiu
authors.forename: Tailin
authors.initials: T
authors.lastname: Cui
authors.forename: Atsuhide
authors.initials: A
authors.lastname: Hamada
authors.forename: Saburo
authors.initials: S
authors.lastname: Yoshioka
authors.forename: Masahide
authors.initials: M
authors.lastname: Ono
authors.forename: Mitsuhiko
authors.initials: M
authors.lastname: Miyamura
authors.forename: Shojiro
authors.initials: S
authors.lastname: Kyotani
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Nishioka
mesh_terms: D000818:Animals; D004128:Dimethylnitrosamine / Q000633:toxicity*; D004305:Dose-Response Relationship, Drug; D004365:Drugs, Chinese Herbal / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use*; D007249:Inflammation / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology; D008099:Liver / Q000187:drug effects* / Q000473:pathology*; D008106:Liver Cirrhosis, Experimental / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008517:Phytotherapy / Q000379:methods; D051381:Rats; D017208:Rats, Wistar
chemical_list: D004365:Drugs, Chinese Herbal; C461320:shosaiko-to; D004128:Dimethylnitrosamine